Growth-hormone secretagogue · Fact sheet
Hexarelin
Also known as Examorelin
Hexarelin stimulates growth hormone and can also affect other hormones. Small human experiments do not prove muscle or recovery benefits, and one sleep study found less deep sleep rather than an improvement.
What is Hexarelin?
Hexarelin is a synthetic peptide studied through the growth-hormone secretagogue pathway. It is not selective for a single hormone response under every experimental condition.
Benefits & claims
Muscle growth, recovery, and deeper sleep are common expectations. The available human studies mainly measure hormones, and some findings run against the sleep claim.
What the evidence supports
- Acute studies document growth-hormone release, with prolactin and cortisol changes under some conditions.
- The longer endocrine study did not find persistent overstimulation of the measured adrenal and prolactin responses; this is narrower than proving overall safety.
Research areas
- Growth-hormone secretion
- Pituitary-adrenal signaling
- Sleep architecture
Dosage & frequency
Human study contextHexarelin has short human hormone-response studies, but no established FDA-approved treatment dose for recovery, muscle gain, or cardiac health.
Human endocrine dose-response experiment
Healthy adult men
- Amount
- Separate experimental amounts up to 1 mcg/kg
- Frequency
- Acute study administrations
- Route studied or labeled
- Intravenous
Measured GH, prolactin and cortisol release; not a clinical recovery or anti-aging regimen.
How to read these amounts
An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.
Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences
Formulations, interactions & practical context
Formulation differences
- A GH response is a pharmacodynamic finding, not proof of durable clinical benefit.
Interactions & precautions
- Short endocrine studies do not establish safety with other hormone treatments; repeated-use interaction data remain insufficient.
What is still unresolved
- Repeated-use efficacy, tolerance, endocrine effects, and clinical safety remain unresolved.
Side effects & risks
- A seven-person experiment found reduced stage-4 sleep and delta activity, with increased cortisol and other hormones.
- Acute and repeated-exposure findings differ, so a single hormone result cannot predict long-term effects.
This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.
Clinical research
Early human evidenceAcute endocrine experiments and small short-term studies demonstrate biological activity. A seven-person sleep study and a 16-week endocrine study are too limited to establish broad benefits or long-term safety.
Studies
Acute growth-hormone, prolactin, and cortisol response study.
Seven-volunteer study showing reduced deep-sleep measures.
16-week study; no persistent adrenal or prolactin overstimulation in the measured outcomes.
Personal experiences
Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.
Explore 4 sourced accounts by reported effect.
Weight: reported experiences
Warmth, racing thoughts and perceived gym gains
A commenter later described warmth, an energized feeling and racing thoughts that settled, alongside a leaner appearance and somewhat greater strength. Ibutamoren was added later.
Amount, frequency, route and duration could not be confirmed for this account.
Training and combined exposure confound the reported changes. This is an unverified account in a commercially oriented community, not a measured hormone effect.
Read the original accountEnergy: reported experiences
Warmth, racing thoughts and perceived gym gains
A commenter later described warmth, an energized feeling and racing thoughts that settled, alongside a leaner appearance and somewhat greater strength. Ibutamoren was added later.
Amount, frequency, route and duration could not be confirmed for this account.
Training and combined exposure confound the reported changes. This is an unverified account in a commercially oriented community, not a measured hormone effect.
Read the original accountAnxiety and difficulty sleeping
Another commenter described a heavy, tired body but an alert mind, anxiety and poor sleep during a sermorelin–hexarelin combination. Stimulation persisted on a later exposure.
Reported use in this account
- Product
- Hexarelin with sermorelin
- Amount
- Not specified clearly
- Frequency
- Not specified clearly
- Route
- Injection; specific route not stated
- Duration
- About two weeks at the time of the account
Other exposures described: Sermorelin
The compounds cannot be separated. Product identity and the mechanism suggested by replies were not verified.
Read the original accountBetter perceived sleep with numb hands and marked tiredness
A forum diary author described good sleep after an approximately 50 mcg evening Hexarelin exposure, but numb hands on waking and pronounced tiredness after another exposure. CJC-1295 with DAC and other drugs were also involved.
Reported use in this account
- Product
- Product described as Hexarelin
- Amount
- About 50 mcg for the evening exposures described
- Frequency
- Two evening exposures described; overall frequency varied
- Route
- Subcutaneous, stated in the author's later reply
- Duration
- Not specified clearly
Other exposures described: CJC-1295 with DAC; Trenbolone; Pramipexole; Zinc; discussed by the author
The author acknowledges being a commercial representative. Combined drugs, changing amounts and unverified products prevent attributing sleep or numbness to Hexarelin; no hormone result or safety claim is verified.
Read the mixed forum diarySleep: reported experiences
Anxiety and difficulty sleeping
Another commenter described a heavy, tired body but an alert mind, anxiety and poor sleep during a sermorelin–hexarelin combination. Stimulation persisted on a later exposure.
Reported use in this account
- Product
- Hexarelin with sermorelin
- Amount
- Not specified clearly
- Frequency
- Not specified clearly
- Route
- Injection; specific route not stated
- Duration
- About two weeks at the time of the account
Other exposures described: Sermorelin
The compounds cannot be separated. Product identity and the mechanism suggested by replies were not verified.
Read the original accountBetter perceived sleep with numb hands and marked tiredness
A forum diary author described good sleep after an approximately 50 mcg evening Hexarelin exposure, but numb hands on waking and pronounced tiredness after another exposure. CJC-1295 with DAC and other drugs were also involved.
Reported use in this account
- Product
- Product described as Hexarelin
- Amount
- About 50 mcg for the evening exposures described
- Frequency
- Two evening exposures described; overall frequency varied
- Route
- Subcutaneous, stated in the author's later reply
- Duration
- Not specified clearly
Other exposures described: CJC-1295 with DAC; Trenbolone; Pramipexole; Zinc; discussed by the author
The author acknowledges being a commercial representative. Combined drugs, changing amounts and unverified products prevent attributing sleep or numbness to Hexarelin; no hormone result or safety claim is verified.
Read the mixed forum diaryMood: reported experiences
Anxiety and difficulty sleeping
Another commenter described a heavy, tired body but an alert mind, anxiety and poor sleep during a sermorelin–hexarelin combination. Stimulation persisted on a later exposure.
Reported use in this account
- Product
- Hexarelin with sermorelin
- Amount
- Not specified clearly
- Frequency
- Not specified clearly
- Route
- Injection; specific route not stated
- Duration
- About two weeks at the time of the account
Other exposures described: Sermorelin
The compounds cannot be separated. Product identity and the mechanism suggested by replies were not verified.
Read the original accountStrength: reported experiences
Warmth, racing thoughts and perceived gym gains
A commenter later described warmth, an energized feeling and racing thoughts that settled, alongside a leaner appearance and somewhat greater strength. Ibutamoren was added later.
Amount, frequency, route and duration could not be confirmed for this account.
Training and combined exposure confound the reported changes. This is an unverified account in a commercially oriented community, not a measured hormone effect.
Read the original accountEndurance: reported experiences
More perceived gym stamina
A separate commenter reported greater stamina after about one week, while explicitly saying it was too early to judge muscle changes.
Reported use in this account
- Product
- Product described as hexarelin
- Amount
- Not specified clearly
- Frequency
- Not specified clearly
- Route
- Not specified clearly
- Duration
- About one week
The account is brief, with no measured performance or long-term follow-up.
Read the original accountSensory changes: reported experiences
Better perceived sleep with numb hands and marked tiredness
A forum diary author described good sleep after an approximately 50 mcg evening Hexarelin exposure, but numb hands on waking and pronounced tiredness after another exposure. CJC-1295 with DAC and other drugs were also involved.
Reported use in this account
- Product
- Product described as Hexarelin
- Amount
- About 50 mcg for the evening exposures described
- Frequency
- Two evening exposures described; overall frequency varied
- Route
- Subcutaneous, stated in the author's later reply
- Duration
- Not specified clearly
Other exposures described: CJC-1295 with DAC; Trenbolone; Pramipexole; Zinc; discussed by the author
The author acknowledges being a commercial representative. Combined drugs, changing amounts and unverified products prevent attributing sleep or numbness to Hexarelin; no hormone result or safety claim is verified.
Read the mixed forum diaryApproval status
Hexarelin has no FDA-approved therapeutic product. The cited endocrine experiments document historical human research, not an established approved recovery or sleep treatment.
Historical human studies; no FDA approval
Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.
Open questions
- Clinical benefits for muscle or injury recovery
- Long-term metabolic and endocrine safety
- Whether effects differ across populations and products
Summary
Hexarelin has measurable hormone effects, but little evidence that those changes deliver the consumer benefits often claimed.
Sources
Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.
- pubmedHexarelin endocrine responses in humans
Acute growth-hormone, prolactin, and cortisol response study.
- pubmedHexarelin and human sleep-endocrine activity
Seven-volunteer study showing reduced deep-sleep measures.
- pubmedRepeated hexarelin exposure and the pituitary-adrenal axis
16-week study; no persistent adrenal or prolactin overstimulation in the measured outcomes.